Commercial-stage genomic-technology company.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Funding round Biofidelity, a Cambridge genomic-technology biotech, raised $24M from investors including Octopus Ventures and Agilent Technologies. | $24M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.